gliotoxin has been researched along with Candidiasis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ford, HR; Potoka, DA; Upperman, JS; Wong, K; Zamora, R; Zhang, XR | 1 |
Dietz, A; Geginat, G; Hof, H; Kupfahl, C; Ruppert, T | 1 |
Glover, DD; Larsen, B; Shah, DT | 1 |
Larsen, B; Shah, DT | 1 |
4 other study(ies) available for gliotoxin and Candidiasis
Article | Year |
---|---|
Mechanism of intestinal-derived fungal sepsis by gliotoxin, a fungal metabolite.
Topics: Animals; Apoptosis; Candidiasis; Cell Line; Dose-Response Relationship, Drug; Gliotoxin; Intestinal Diseases; Rats; Sepsis; Time Factors | 2003 |
Candida species fail to produce the immunosuppressive secondary metabolite gliotoxin in vitro.
Topics: Candida; Candidiasis; Chromatography, High Pressure Liquid; Gliotoxin; Humans; Immunosuppressive Agents; Tandem Mass Spectrometry; Virulence | 2007 |
In situ mycotoxin production by Candida albicans in women with vaginitis.
Topics: Candida albicans; Candidiasis; Case-Control Studies; Female; Gliotoxin; Humans; Immune Tolerance; Virulence; Vulvovaginitis | 1995 |
Clinical isolates of yeast produce a gliotoxin-like substance.
Topics: Aspergillus fumigatus; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Culture Media; Gliotoxin; Humans; Virulence | 1991 |